Does type of immunosupression influence the course of Covid-19 infection?
Covid-19
cancer
immunosupression
poor outcomes
Journal
The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
23
05
2020
accepted:
30
05
2020
pubmed:
7
6
2020
medline:
4
8
2020
entrez:
7
6
2020
Statut:
ppublish
Résumé
Coronavirus disease 19 (Covid-19) is a new emerging virus responsible for pandemic and death. High blood pressure, diabetes, obesity have been described as poor prognosis factors. Few data have been reported in patient with immunocompromised status (solid tumor, hematological malignancy, rheumatoid conditions or organ transplant). We evaluated the characteristics of patients, including the outcome, with immunodepression hospitalized in Besancon University hospital (East of France). We wanted to identify if a type of immunosupression influences the course of Covid-19. In a cohort of 80 patients with immunosupression (42 solid tumors, 20 hematological malignancy and 18 non neoplastic immunosupression), poor outcomes (Intensive care unit hospitalization and or deaths) was frequent (38%) and tended to be more frequent in patients with hematological malignancy.
Identifiants
pubmed: 32504741
pii: S0163-4453(20)30351-0
doi: 10.1016/j.jinf.2020.05.075
pmc: PMC7834486
pii:
doi:
Types de publication
Letter
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
e132-e135Commentaires et corrections
Type : CommentOn
Type : CommentOn
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no competing financial interest and received no grants related to this study.
Références
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
N Engl J Med. 2020 Jun 18;382(25):2441-2448
pubmed: 32356628
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Infect. 2020 Aug;81(2):e93-e95
pubmed: 32417309
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
Ann Rheum Dis. 2020 May;79(5):667-668
pubmed: 32241793
J Infect. 2020 Jul;81(1):e61-e66
pubmed: 32335173
Nat Immunol. 2003 Jan;4(1):69-77
pubmed: 12483210
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059